A Chinese Covid mRNA vaccine got its first ever emergency use authorization, receiving approval from Indonesia this week, according to reports from Reuters and the People’s Daily.
The mRNA shot co-developed by Walvax Biotechnology Co, Suzhou Abogen Biosciences Co. and the Chinese military has been cleared for use in people aged 18 or older, the People’s Daily said, citing the Indonesian drug regulator.